We have successfully closed our latest funding round with SFC and KIN Capital leading it, award winning investors, both joining last week our multinational shareholder's board supporting OIA.
This is a major milestone as other startups and companies find it increasingly difficult to find funding in a time of crisis. We are very proud to have SFC and KIN joining OIA's journey and for the trust placed on us by investors of this calibre, it feels very much like validation of what we have been doing in the last 1.5 years developing Algocyte®.
We are thrilled that SFC and KIN have seen value in OIA even (or especially) in times like a pandemic. Their investment will help us respond to the increasing interest we are seeing in our services from the NHS. We will now start our next funding round and it is already looking very promising as we are in advanced talks with some of the largest and greatest VCs in the UK.